Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Considering the APOE locus in polygenic scores for Alzheimer’s disease

View ORCID ProfileErin B. Ware, Jessica D. Faul, View ORCID ProfileColter M. Mitchell, View ORCID ProfileKelly M. Bakulski
doi: https://doi.org/10.1101/2019.12.10.19014365
Erin B. Ware
1Population, Neurodevelopment, and Genetics, Survey Research Center, Institute for Social Research, University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erin B. Ware
  • For correspondence: ebakshis@umich.edu
Jessica D. Faul
1Population, Neurodevelopment, and Genetics, Survey Research Center, Institute for Social Research, University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colter M. Mitchell
1Population, Neurodevelopment, and Genetics, Survey Research Center, Institute for Social Research, University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Colter M. Mitchell
Kelly M. Bakulski
2Department of Epidemiology, School of Public Health, University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kelly M. Bakulski
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Polygenic scores are a strategy to aggregate the small, additive effects of single nucleotide polymorphisms across the genome. With phenotypes like Alzheimer’s disease, which have a strong and well established genomic locus (APOE), the cumulative effect of genetic variants outside of this area has not been well established in a population-representative sample. Here we examine the association between polygenic scores both with and without the APOE region at different P value thresholds. We also investigate the addition of APOE-ε4 carrier status and its effect on the polygenic score – dementia association. We found that including the APOE region through weighted variants in a polygenic score was insufficient to capture the large amount of risk attributed to this region. We recommend removing this region from polygenic score calculation and treating the APOE locus as an independent covariate.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by grants from the National Institutes of Health (NIA R01 AG055406, NIA RF1 AG055654, NIMHD R01 MD011716).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding This work was supported by grants from the National Institutes of Health (NIA R01 AG055406, NIA RF1 AG055654, NIMHD R01 MD011716).

  • Acronyms: Alzheimer’s disease (AD), Apolipoprotein E (APOE), confidence interval (CI), genome-wide association study (GWAS), Health and Retirement Study (HRS), International Genomics of Alzheimer’s Project (IGAP), odds ratio (OR), polygenic risk score (PGS), principal component (PC), p-value threshold (pT), single nucleotide polymorphism (SNP), 1000 Genomes Project (1000GP)

Data Availability

All data from these analyses are available through the Health and Retirement Study (https://hrs.isr.umich.edu/) or the database of genotypes and phenotypes (dbGaP https://www.ncbi.nlm.nih.gov/gap/, phs000428.v2.p2).

https://www.niagads.org/datasets/ng00075

https://www.ncbi.nlm.nih.gov/gap/

https://hrs.isr.umich.edu/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 14, 2019.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Considering the APOE locus in polygenic scores for Alzheimer’s disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Considering the APOE locus in polygenic scores for Alzheimer’s disease
Erin B. Ware, Jessica D. Faul, Colter M. Mitchell, Kelly M. Bakulski
medRxiv 2019.12.10.19014365; doi: https://doi.org/10.1101/2019.12.10.19014365
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Considering the APOE locus in polygenic scores for Alzheimer’s disease
Erin B. Ware, Jessica D. Faul, Colter M. Mitchell, Kelly M. Bakulski
medRxiv 2019.12.10.19014365; doi: https://doi.org/10.1101/2019.12.10.19014365

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (196)
  • Anesthesia (54)
  • Cardiovascular Medicine (489)
  • Dentistry and Oral Medicine (89)
  • Dermatology (56)
  • Emergency Medicine (168)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
  • Epidemiology (5681)
  • Forensic Medicine (3)
  • Gastroenterology (215)
  • Genetic and Genomic Medicine (866)
  • Geriatric Medicine (88)
  • Health Economics (231)
  • Health Informatics (762)
  • Health Policy (390)
  • Health Systems and Quality Improvement (252)
  • Hematology (105)
  • HIV/AIDS (182)
  • Infectious Diseases (except HIV/AIDS) (6474)
  • Intensive Care and Critical Care Medicine (390)
  • Medical Education (117)
  • Medical Ethics (28)
  • Nephrology (92)
  • Neurology (847)
  • Nursing (44)
  • Nutrition (141)
  • Obstetrics and Gynecology (163)
  • Occupational and Environmental Health (260)
  • Oncology (514)
  • Ophthalmology (163)
  • Orthopedics (44)
  • Otolaryngology (106)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (250)
  • Pharmacology and Therapeutics (146)
  • Primary Care Research (114)
  • Psychiatry and Clinical Psychology (966)
  • Public and Global Health (2228)
  • Radiology and Imaging (377)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (312)
  • Rheumatology (109)
  • Sexual and Reproductive Health (80)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)